Tracking HPV DNA in blood after cervical cancer surgery
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at whether monitoring HPV DNA in your blood after surgery can help predict if cervical cancer comes back, and whether this information can guide decisions about extra treatment. If you join, you'll provide blood samples before and after surgery to track your HPV levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cervical cancer that is HPV-related (not HPV-negative).
- Your cancer is at an early stage (FIGO stage IB1 to IIB) and you are scheduled for radical surgery.
- You have a detectable HPV type in your tumor or blood that can be tracked.
- If you had chemotherapy before surgery, you must have HPV test results from before that treatment.
- You are willing to give blood samples and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood samples from women with HPV-related cervical cancer to see if a test can detect tiny bits of cancer DNA (molecular residual disease) and predict if the cancer might come back. Finding this DNA early could help guide future treatment decisions.
This trial checks how well cervical cancer responds to surgery, radiation, and chemotherapy by measuring HPV DNA and RNA in blood and cervical mucus. It aims to improve monitoring during treatment.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This study checks whether “liquid biopsies” (blood tests that look for cancer-related signals) can help monitor how HPV-related cancers respond to treatment. It may help doctors spot changes earlier during care.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.